Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments

NeuroImage: Clinical

Volumn 12, Issue , 2016, Pages e1-e9

  Rahmim, Arman ^a,b   Salimpour, Yousef ^c   Jain, Saurabh ^b   Blinder, Stephan A L ^d   Klyuzhin, Ivan S ^d   Smith, Gwenn S ^e   Mari, Zoltan ^c   Sossi, Vesna ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Johns Hopkins University   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

DAT SPECT; Disease progression; Heterogeneity; Parkinson's disease; Textural features

Indexed keywords

DOPAMINE TRANSPORTER; IOFLUPANE; NORTROPANE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MONTREAL COGNITIVE ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNIFIED PARKINSON DISEASE RATING SCALE; AGED; ANALYSIS OF VARIANCE; DIAGNOSTIC IMAGING; FEMALE; MALE; METABOLISM; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

AGED; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NORTROPANES; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84961116725     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2016.02.012     Document Type: Article

References (61)

1. Aerts, H.J.W.L., Velazquez, E.R., Leijenaar, R.T.H., Parmar, C., Grossmann, P., Carvalho, S., Bussink, J., Monshouwer, R., Haibe-Kains, B., Rietveld, D., Hoebers, F., Rietbergen, M.M., Leemans, C.R., Dekker, A., Quackenbush, J., Gillies, R.J., Lambin, P., Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat. Commun., 5, 2014, 4006.
2. Asselin, M.C., O'Connor, J.P.B., Boellaard, R., Thacker, N.A., Jackson, A., Quantifying heterogeneity in human tumours using MRI and PET. Eur. J. Cancer 48 (2012), 447–455.
3. Badiavas, K., Molyvda, E., Iakovou, I., Tsolaki, M., Psarrakos, K., Karatzas, N., SPECT imaging evaluation in movement disorders: far beyond visual assessment. Eur. J. Nucl. Med. Mol. Imaging 38 (2011), 764–773.
4. Blinder, S., Klyuzhin, I., Gonzalez, M.E., Rahmim, A., Sossi, V., Texture and shape analysis on high and low spatial resolution emission images. Proc. IEEE Nucl. Sci. Symp. Conf., 2014.
5. Bostan, A.C., Dum, R.P., Strick, P.L., The basal ganglia communicate with the cerebellum. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 8452–8456.
6. Brooks, D.J., Ibanez, V., Sawle, G.V., Quinn, N., Lees, A.J., Mathias, C.J., Bannister, R., Marsden, C.D., Frackowiak, R.S.J., differing patterns of striatal f-18 dopa uptake in parkinsons-disease, multiple system atrophy, and progressive supranuclear palsy. Ann. Neurol. 28 (1990), 547–555.
7. Catafau, A.M., Tolosa, E., Impact of dopamine transporter SPECT using I-123-ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov. Disord. 19 (2004), 1175–1182.
8. Chicklore, S., Goh, V., Siddique, M., Roy, A., Marsden, P.K., Cook, G.J.R., Quantifying tumour heterogeneity in F-18-FDG PET/CT imaging by texture analysis. Eur. J. Nucl. Med. Mol. Imaging 40 (2013), 133–140.
9. Cohen, J., A coefficient of agreement for nominal scales. Educ. Psychol. Meas. 20 (1960), 37–46.
10. Conners, R.W., Harlow, C.A., Toward a structural textural analyzer based on statistical-methods. Computer Graphics and Image Processing 12 (1980), 224–256.
11. Conners, R.W., Trivedi, M.M., Harlow, C.A., Segmentation of a High-resolution urban scene using texture operators. Computer Vision Graphics and Image Processing 25 (1984), 273–310.
12. de la Riva, P., Smith, K., Xie, S.X., Weintraub, D., Course of psychiatric symptoms and global cognition in early Parkinson disease. Neurology 83 (2014), 1096–1103.
13. Djang, D.S.W., Janssen, M.J.R., Bohnen, N., Booij, J., Henderson, T.A., Herholz, K., Minoshima, S., Rowe, C.C., Sabri, O., Seibyl, J., Van Berckel, B.N.M., Wanner, M., SNM practice guideline for dopamine transporter imaging with I-123-ioflupane SPECT 1.0. J. Nucl. Med. 53 (2012), 154–163.
14. Eary, J.F., O'Sullivan, F., O'Sullivan, J., Conrad, E.U., Spatial heterogeneity in sarcoma (18)F-FDG uptake as a predictor of patient outcome. J. Nucl. Med. 49 (2008), 1973–1979.
15. Echegaray, S., Gevaert, O., Shah, R., Kamaya, A., Louie, J., Kothary, N., Napel, S., Core samples for radiomics features that are insensitive to tumor segmentation: method and pilot study using CT images of hepatocellular carcinoma. J. Med. Imaging, 2, 2015, 041011.
16. El Naqa, I., Grigsby, P.W., Apte, A., Kidd, E., Donnelly, E., Khullar, D., Chaudhari, S., Yang, D., Schmitt, M., Laforest, R., Thorstad, W.L., Deasy, J.O., Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recogn. 42 (2009), 1162–1171.
17. Garnett, E.S., Lang, A.E., Chirakal, R., Firnau, G., Nahmias, C., A rostrocaudal gradient for aromatic acid decarboxylase in the human striatum. Can. J. Neurol. Sci. 14 (1987), 444–447.
18. Gonzalez, M.E., Dinelle, K., Vafai, N., Heffernan, N., McKenzie, J., Appel-Cresswell, S., McKeown, M.J., Stoessl, A.J., Sossi, V., Novel spatial analysis method for PET images using 3D moment invariants: applications to Parkinson's disease. NeuroImage 68 (2013), 11–21.
19. Grachev, I., Kupsch, A., Bajaj, N., Weiland, F., Tartaglione, A., Klutmann, S., Buitendyk, M., Sherwin, P., Tate, A., Impact of DaTscan (TM) SPECT imaging on clinical management, diagnosis, and confidence of diagnosis in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up study. Neurology, 78, 2012.
20. Grkovski, M., Apte, A., Schwartz, J., Rimner, A., Schoder, H., Carlin, S., Zanzonico, P., Humm, J., Nehmeh, S., Reproducibility of F-18-FMISO intratumor distribution and texture features in NSCLC. J. Nucl. Med., 56, 2015.
21. Gustafsson, H., Nordstrom, A., Nordstrom, P., Depression and subsequent risk of Parkinson disease: a nationwide cohort study. Neurology 84 (2015), 2422–2429.
22. Haralick, R.M., Shanmuga, K., Dinstein, I., Textural features for image classification. IEEE Transactions on Systems Man and Cybernetics Smc3, 1973, 610–621.
23. Hariri, A.R., Weinberger, D.R., Imaging genomics. Br. Med. Bull. 65 (2003), 259–270.
24. Hatt, M., Majdoub, M., Vallieres, M., Tixier, F., Le Rest, C.C., Groheux, D., Hindie, E., Martineau, A., Pradier, O., Hustinx, R., Perdrisot, R., Guillevin, R., El Naqa, I., Visvikis, D., F-18-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort. J. Nucl. Med. 56 (2015), 38–44.
25. Initiative, P.s.P.M., PPMI: Imaging Technical Operations Manual. third ed., 2012, Coordinating Center of PPMI Imaging, New Haven, CT.
26. Jenkinson, M., Smith, S., A global optimisation method for robust affine registration of brain images. Med. Image Anal. 5 (2001), 143–156.
27. Kerns, S.L., de Ruysscher, D., Andreassen, C.N., Azria, D., Barnett, G.C., Chang-Claude, J., Davidson, S., Deasy, J.O., Dunning, A.M., Ostrer, H., Rosenstein, B.S., West, C.M.L., Bentzen, S.M., STROGAR — STrengthening the Reporting Of Genetic Association studies in Radiogenomics. Radiother. Oncol. 110 (2014), 182–188.
28. Kish, S.J., Shannak, K., Hornykiewicz, O., Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N. Engl. J. Med. 318 (1988), 876–880.
29. Klyuzhin, I.S., Gonzalez, M., Shahinfard, E., Vafai, N., Sossi, V., Exploring the use of shape and texture descriptors of PET tracer distribution in imaging studies of neurodegenerative disease. J. Cereb. Blood Flow Metab., 2015, 10.1177/0271678X15606718 (In Press).
30. Koch, W., Radau, P.E., Hamann, C., Tatsch, K., Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J. Nucl. Med. 46 (2005), 1109–1118.
31. Kumar, V., Gu, Y.H., Basu, S., Berglund, A., Eschrich, S.A., Schabath, M.B., Forster, K., Aerts, H.J.W.L., Dekker, A., Fenstermacher, D., Goldgof, D.B., Hall, L.O., Lambin, P., Balagurunathan, Y., Gatenby, R.A., Gillies, R.J., Radiomics: the process and the challenges. Magn. Reson. Imaging 30 (2012), 1234–1248.
32. Kupsch, A.R., Bajaj, N., Weiland, F., Tartaglione, A., Klutmann, S., Buitendyk, M., Sherwin, P., Tate, A., Grachev, I.D., Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study. J. Neurol. Neurosurg. Psychiatry 83 (2012), 620–628.
33. Lambin, P., Rios-Velazquez, E., Leijenaar, R., Carvalho, S., van Stiphout, R.G.P.M., Granton, P., Zegers, C.M.L., Gillies, R., Boellard, R., Dekker, A., Aerts, H.J.W.L., Consortium, Q.-C., Radiomics: Extracting more information from medical images using advanced feature analysis. Eur. J. Cancer 48 (2012), 441–446.
34. Leijenaar, R.T.H., Carvalho, S., Velazquez, E.R., Van Elmpt, W.J.C., Parmar, C., Hoekstra, O.S., Hoekstra, C.J., Boellaard, R., Dekker, A.L.A.J., Gillies, R.J., Aerts, H.J.W.L., Lambin, P., Stability of FDG-PET Radiomics features: An integrated analysis of test–retest and inter-observer variability. Acta Oncol. 52 (2013), 1391–1397.
35. Martinez-Murcia, F.J., Gorriz, J.M., Ramirez, J., Moreno-Caballero, M., Gomez-Rio, M., Ini, P.P.M., Parametrization of textural patterns in I-123-ioflupane imaging for the automatic detection of Parkinsonism. Med. Phys., 41, 2014.
36. Medland, S.E., Jahanshad, N., Neale, B.M., Thompson, P.M., Whole-genome analyses of whole-brain data: working within an expanded search space. Nat. Neurosci. 17 (2014), 791–800.
37. Nalls, M.A., McLean, C.Y., Rick, J., Eberly, S., Hutten, S.J., Gwinn, K., Sutherland, M., Martinez, M., Heutink, P., Williams, N.M., Hardy, J., Gasser, T., Brice, A., Price, T.R., Nicolas, A., Keller, M.F., Molony, C., Gibbs, J.R., Chen-Plotkin, A., Suh, E., Letson, C., Fiandaca, M.S., Mapstone, M., Federoff, H.J., Noyce, A.J., Morris, H., Van Deerlin, V.M., Weintraub, D., Zabetian, C., Hernandez, D.G., Lesage, S., Mullins, M., Conley, E.D., Northover, C.A., Frasier, M., Marek, K., Day-Williams, A.G., Stone, D.J., Ioannidis, J.P., Singleton, A.B., Parkinson's Disease Biomarkers, P., Parkinson's Progression Marker Initiative, Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study. Lancet Neurol. 14:10 (2015), 1002–1009.
38. Nandhagopal, R., Kuramoto, L., Schulzer, M., Mak, E., Cragg, J., Lee, C.S., McKenzie, J., McCormick, S., Samii, A., Troiano, A., Ruth, T.J., Sossi, V., de la Fuente-Fernandez, R., Calne, D.B., Stoessl, A.J., Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. Brain 132 (2009), 2970–2979.
39. Nandhagopal, R., Kuramoto, L., Schulzer, M., Mak, E., Cragg, J., McKenzie, J., McCormick, S., Ruth, T.J., Sossi, V., de la Fuente-Fernandez, R., Stoessl, A.J., Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease. Brain 134 (2011), 3290–3298.
40. Nandhagopal, R., Mak, E., Schulzer, M., McKenzie, J., McCormick, S., Sossi, V., Ruth, T.J., Strongosky, A., Farrer, M.J., Wszolek, Z.K., Stoessl, A.J., Progression of dopaminergic dysfunction in a LRRK2 kindred A multitracer PET study. Neurology 71 (2008), 1790–1795.
41. Noh, Y., Sung, Y.H., Lee, J., Kim, E.Y., Nigrosome 1 detection at 3 T MRI for the diagnosis of early-stage idiopathic Parkinson disease: assessment of diagnostic accuracy and agreement on imaging asymmetry and clinical laterality. AJNR Am. J. Neuroradiol., 2015.
42. Oh, G., Lee, S., Shin, S.Y., Fast determination of textural periodicity using distance matching function. Pattern Recogn. Lett. 20 (1999), 191–197.
43. Parkinson Progression Marker, I., The Parkinson Progression Marker Initiative (PPMI). Prog. Neurobiol. 95 (2011), 629–635.
44. Parkkinen, J., Selkainaho, K., Oja, E., Detecting texture periodicity from the cooccurrence matrix. Pattern Recogn. Lett. 11 (1990), 43–50.
45. Piggott, M.A., Marshall, E.F., Thomas, N., Lloyd, S., Court, J.A., Jaros, E., Burn, D., Johnson, M., Perry, R.H., McKeith, I.G., Ballard, C., Perry, E.K., Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain 122:Pt 8 (1999), 1449–1468.
46. Rahmim, A., Coughlin, J., Gonzalez, M., Endres, C.J., Zhou, Y., Wong, D.F., Wahl, R.L., Sossi, V., Pomper, M.G., Novel parametric PET image quantification using texture and shape analysis. Proc. IEEE Nucl. Sci. Symp. Conf., 2012, 2227–2230.
47. Rahmim, A., Schmidtlein, C.R., Jackson, A., Sheikhbahaei, S., Marcus, C., Ashrafinia, S., Soltani, M., Subramaniam, R.M., A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction. Phys. Med. Biol. 61 (2016), 227–242.
48. Salimpour, Y., Jain, S., Smith, G., Mari, Z., Sossi, V., Rahmim, A., Investigating the regional correlation of subcortical structures as imaged by DAT SPECT with clinical phenotypes in Parkinson's disease. J. Nucl. Med., 56, 2015, 1577.
49. Salimpour, Y., Shadmehr, R., Motor costs and the coordination of the two arms. J. Neurosci. 34 (2014), 1806–1818.
50. Singh, G., Samavedham, L., Unsupervised learning based feature extraction for differential diagnosis of neurodegenerative diseases: a case study on early-stage diagnosis of Parkinson disease. J. Neurosci. Methods, 2015.
51. Sossi, V., de la Fuente-Fernandez, R., Nandhagopal, R., Schulzer, M., McKenzie, J., Ruth, T.J., Aasly, J.O., Farrer, M.J., Wszolek, Z.K., Stoessl, J.A., Dopamine turnover increases in asymptomatic LRRK2 mutations carriers. Mov. Disord. 25 (2010), 2717–2723.
52. Sossi, V., Gonzalez, M., Dinelle, K., Heffernan, N., McKenzie, J., Cresswell, S., McKeown, M.J., Stoessl, A.J., New insights into levodopa induced dopamine release in Parkinson's disease. J. Cereb. Blood Flow Metab., 32(Suppl. 1), 2012, P114.
53. Stoessl, A.J., Martin, W.R.W., McKeown, M., Sossi, V., Advances in imaging in Parkinson's disease. Lancet Neurol. 10 (2011), 987–1001.
54. Suwijn, S.R., van Boheemen, C.J., de Haan, R.J., Tissingh, G., Booij, J., de Bie, R.M., The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review. EJNMMI Res., 5, 2015, 12.
55. Tang, X.Y., Oishi, K., Faria, A.V., Hillis, A.E., Albert, M.S., Mori, S., Miller, M.I., Bayesian parameter estimation and segmentation in the multi-atlas random orbit model. PLoS One, 8, 2013.
56. Tixier, F., Hatt, M., Le Rest, C.C., Le Pogam, A., Corcos, L., Visvikis, D., Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in F-18-FDG PET. J. Nucl. Med. 53 (2012), 693–700.
57. Tixier, F., Hatt, M., Valla, C., Fleury, V., Lamour, C., Ezzouhri, S., Ingrand, P., Perdrisot, R., Visvikis, D., Le Rest, C.C., Visual versus quantitative assessment of intratumor F-18-FDG PET uptake heterogeneity: prognostic value in non-small cell lung cancer. J. Nucl. Med. 55 (2014), 1235–1241.
58. Tixier, F., Le Rest, C.C., Hatt, M., Albarghach, N., Pradier, O., Metges, J.P., Corcos, L., Visvikis, D., Intratumor heterogeneity characterized by textural features on Baseline (18)F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J. Nucl. Med. 52 (2011), 369–378.
59. van Velden, F., Kramer, G., Frings, V., Nissen, I., Mulder, E., de Langen, A.J., Hoekstra, O., Smit, E., Boellaard, R., Repeatability of radiomics features in non-small cell lung cancer FDG-PET/CT studies: impact of reconstruction and delineation. Mol. Imaging Biol., 2016 (In Print).
60. van Velden, F.H.P., Cheebsumon, P., Yaqub, M., Smit, E.F., Hoekstra, O.S., Lammertsma, A.A., Boellaard, R., Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies. Eur. J. Nucl. Med. Mol. Imaging 38 (2011), 1636–1647.
61. Vriens, D., Disselhorst, J.A., Oyen, W.J.G., de Geus-Oei, L.F., Visser, E.P., Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET. Int. J. Radiat. Oncol. Biol. Phys. 82 (2012), E725–E731.